Maryland's False Claims Act Doesn't Go Far Enough Mar 31

Last week, the Maryland Senate passed legislation amending Maryland’s False Claims Act . While the bill passed with nearly a ...

Celiac Sufferer Sues FDA to Remove Gluten from Drugs Mar 30

On March 16, 2015, a New York man filed suit in U.S. District Court for the District of Columbia asking a judge order the Food and ...

Generic Drug Maker Liability: New Change to an Old Regime Mar 24

Different rules exist for generic drug manufacturers and brand-name drug manufacturers with regard to their warning labels. The ...

Xarelto Update: FDA Denies Applications Mar 19

Last month, the Food & Drug Administration rejected two applications submitted to expand the use of Xarelto (rivaroxaban) . ...

SEC Whistleblower Program Mar 16

Although relatively new, the Securities and Exchange Commission (SEC) whistleblower program and its implementation have shown a ...

Testosterone Risks: FDA Requires New Warning Label Mar 10

The FDA now requires a warning label to inform the public of a possible increase of heart attack and stroke in prescription ...